310 related articles for article (PubMed ID: 29727307)
41. Neuropsychological effects and attitudes in patients following electroconvulsive therapy.
Feliu M; Edwards CL; Sudhakar S; McDougald C; Raynor R; Johnson S; Byrd G; Whitfield K; Jonassaint C; Romero H; Edwards L; Wellington C; Hill LK; Sollers J; Logue PE
Neuropsychiatr Dis Treat; 2008 Jun; 4(3):613-7. PubMed ID: 18830401
[TBL] [Abstract][Full Text] [Related]
42. The Clinical Practice of Assessing Cognitive Function in Adults Receiving Electroconvulsive Therapy: Whom Are We Missing?
Obbels J; Vanbrabant K; Bouckaert F; Verwijk E; Sienaert P
J ECT; 2016 Jun; 32(2):99-103. PubMed ID: 26421675
[TBL] [Abstract][Full Text] [Related]
43. Naturalistic Study on the Effects of Electroconvulsive Therapy (ECT) on Depressive Symptoms.
Goegan SA; Hasey GM; King JP; Losier BJ; Bieling PJ; McKinnon MC; McNeely HE
Can J Psychiatry; 2022 May; 67(5):351-360. PubMed ID: 34903092
[TBL] [Abstract][Full Text] [Related]
44. Concomitant Anticonvulsants With Bitemporal Electroconvulsive Therapy: A Randomized Controlled Trial With Clinical and Neurobiological Application.
Rakesh G; Thirthalli J; Kumar CN; Muralidharan K; Phutane VH; Gangadhar BN
J ECT; 2017 Mar; 33(1):16-21. PubMed ID: 27668943
[TBL] [Abstract][Full Text] [Related]
45. Use of Electroconvulsive Therapy in Adolescents With Treatment-Resistant Depressive Disorders: A Case Series.
Zhand N; Courtney DB; Flament MF
J ECT; 2015 Dec; 31(4):238-45. PubMed ID: 25830809
[TBL] [Abstract][Full Text] [Related]
46. Usefulness of the Montreal Cognitive Assessment (MoCA) to monitor cognitive impairments in depressed patients receiving electroconvulsive therapy.
Moirand R; Galvao F; Lecompte M; Poulet E; Haesebaert F; Brunelin J
Psychiatry Res; 2018 Jan; 259():476-481. PubMed ID: 29149717
[TBL] [Abstract][Full Text] [Related]
47. Cognitive change after electroconvulsive therapy in mood disorders measured with the Montreal Cognitive Assessment.
Hebbrecht K; Giltay EJ; Birkenhäger TK; Sabbe B; Verwijk E; Obbels J; Roelant E; Schrijvers D; Van Diermen L
Acta Psychiatr Scand; 2020 Nov; 142(5):413-422. PubMed ID: 32895922
[TBL] [Abstract][Full Text] [Related]
48. Neurognitive function and symptom remission 2 years after ECT in major depressive disorders.
Mohn C; Rund BR
J Affect Disord; 2019 Mar; 246():368-375. PubMed ID: 30597298
[TBL] [Abstract][Full Text] [Related]
49. A Brief Measure for Assessing Patient Perceptions of Cognitive Side Effects After Electroconvulsive Therapy: The Subjective Assessment of Memory Impairment.
Kumar DR; Han HK; Tiller J; Loo CK; Martin DM
J ECT; 2016 Dec; 32(4):256-261. PubMed ID: 27295463
[TBL] [Abstract][Full Text] [Related]
50. The Role of Baseline Cognitive Function in the Neurocognitive Effects of Electroconvulsive Therapy in Depressed Elderly Patients.
Dybedal GS; Tanum L; Sundet K; Bjølseth TM
Clin Neuropsychol; 2015; 29(4):487-508. PubMed ID: 26029851
[TBL] [Abstract][Full Text] [Related]
51. "Side effects" of ECT are mainly depressive phenomena and are independent of age.
Brodaty H; Berle D; Hickie I; Mason C
J Affect Disord; 2001 Oct; 66(2-3):237-45. PubMed ID: 11578677
[TBL] [Abstract][Full Text] [Related]
52. Cognitive Effects of Bifrontal Versus Right Unilateral Electroconvulsive Therapy in the Treatment of Major Depression in Elderly Patients: A Randomized, Controlled Trial.
Dybedal GS; Bjølseth TM; Benth JŠ; Tanum L
J ECT; 2016 Sep; 32(3):151-8. PubMed ID: 26909824
[TBL] [Abstract][Full Text] [Related]
53. Relapse and long-term cognitive performance after brief pulse or ultrabrief pulse right unilateral electroconvulsive therapy: A multicenter naturalistic follow up.
Verwijk E; Spaans HP; Comijs HC; Kho KH; Sienaert P; Bouckaert F; Obbels J; Scherder EJ; Stek ML; Kok RM
J Affect Disord; 2015 Sep; 184():137-44. PubMed ID: 26093032
[TBL] [Abstract][Full Text] [Related]
54. Electroconvulsive therapy "corrects" the neural architecture of visuospatial memory: Implications for typical cognitive-affective functioning.
Petrican R; Söderlund H; Kumar N; Daskalakis ZJ; Flint A; Levine B
Neuroimage Clin; 2019; 23():101816. PubMed ID: 31003068
[TBL] [Abstract][Full Text] [Related]
55. Long-term Changes in Cognitive Functioning in Individuals With Psychotic Disorders: Findings From the Suffolk County Mental Health Project.
Fett AJ; Velthorst E; Reichenberg A; Ruggero CJ; Callahan JL; Fochtmann LJ; Carlson GA; Perlman G; Bromet EJ; Kotov R
JAMA Psychiatry; 2020 Apr; 77(4):387-396. PubMed ID: 31825511
[TBL] [Abstract][Full Text] [Related]
56. The effects of lacosamide on cognition, quality-of-life measures, and quality of life in patients with refractory partial epilepsy.
Lancman ME; Fertig EJ; Trobliger RW; Perrine K; Myers L; Iyengar SS; Malik M
Epilepsy Behav; 2016 Aug; 61():27-33. PubMed ID: 27315132
[TBL] [Abstract][Full Text] [Related]
57. Effectiveness and Cognitive Changes With Ultrabrief Right Unilateral and Other Forms of Electroconvulsive Therapy in the Treatment of Mania.
Wong VKH; Tor PC; Martin DM; Mok YM; Loo C
J ECT; 2019 Mar; 35(1):40-43. PubMed ID: 29952862
[TBL] [Abstract][Full Text] [Related]
58. Unilateral brief-pulse electroconvulsive therapy and cognition: effects of electrode placement, stimulus dosage and time.
Semkovska M; Keane D; Babalola O; McLoughlin DM
J Psychiatr Res; 2011 Jun; 45(6):770-80. PubMed ID: 21109254
[TBL] [Abstract][Full Text] [Related]
59. Erythropoietin as an add-on treatment for cognitive side effects of electroconvulsive therapy: a study protocol for a randomized controlled trial.
Schmidt LS; Petersen JZ; Vinberg M; Hageman I; Olsen NV; Kessing LV; Jørgensen MB; Miskowiak KW
Trials; 2018 Apr; 19(1):234. PubMed ID: 29673379
[TBL] [Abstract][Full Text] [Related]
60. Double-blind randomized controlled study showing symptomatic and cognitive superiority of bifrontal over bitemporal electrode placement during electroconvulsive therapy for schizophrenia.
Phutane VH; Thirthalli J; Muralidharan K; Naveen Kumar C; Keshav Kumar J; Gangadhar BN
Brain Stimul; 2013 Mar; 6(2):210-7. PubMed ID: 22560048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
